Y. Luo, B. Wang, G. Zhang, Y. Zhou, and P. Lian
Vol 000
(s, 9H, 3CH3); 13C NMR (DMSO‐d6, 125 MHz) δ, ppm:
182.260, 154.941, 151.791, 138.631, 98.198, 32.557, 28.393;
IR (KBr) υ: 3464, 3343 (NH2), 2968∼2871(CH3), 1632,1553
(furazan) cm−1; Anal. calcd for C7H8N4O4: C 51.92, H 5.769,
N 26.92; found C 51.74, H 5.802, N 26.83; MS (EI) m/z(%):
208 (M+, 40), 151(100), 135(80),109(75), 95(45),43(82).
3‐(4‐Aminofurazan‐3‐yl)‐5‐brommethylisoxazone (3). Yield:
0.44 g (73.0%) m.p.147.28°C (DSC, 10°C min−1); 1H NMR
(DMSO‐d6, 500 MHz) δ, ppm: 7.197(s, H, CH), 6.431(s, 2H,
NH2), 4.949(s, 2H, CH2); 13C NMR(DMSO‐d6, 125 MHz) δ,
ppm: 169.563, 154.937, 152.370, 138.291, 103.087, 19.056;
IR (KBr) υ: 3453, 3325(NH2), 1634,1558(furazan), 733(Cl)
cm−1; Anal. calcd for C6H5N4O2Br: C 29.39, H 2.041, N
22.85; found C 29.54, H 2.235, N 22.81; MS (EI) m/z(%): 244
(M+,27), 246((M+2)+, 27), 187(38), 165(10), 108(83), 68
(100), 53(39),42(15).
3‐(4‐Aminofurazan‐3‐yl)‐5‐chloromethyl‐isoxazone (4).
Yield: 0.33 g (66.9%). m.p.122.72°C (DSC, 10°C min−1);
1H NMR (DMSO‐d6, 500 MHz) δ, ppm: 7.203(s, H, CH),
6.434(s, 2H, NH2), 5.083(s, 2H, CH2); 13C NMR(DMSO‐d6, 125
MHz) δ, ppm: 169.304, 154.963, 152.301, 138.297, 103.286,
33.844; IR (KBr) υ: 3459,3334(NH2), 3259∼3160(CH2),
1634,1558(furazan), 734(Cl) cm−1; Anal. calcd for C6H5N4O2Cl :
C 35.91, H 2.494, N 27.93; found C 35.98, H 2.556, N 27.69; MS
(EI) m/z(%): 200(M+,46), 202((M+2)+, 15), 143(100), 107(17), 68
(76), 58(45),49(28).
Figure 2. Packing of compound 4 molecules in the crystal.
3‐(4‐Aminofurazan‐ 3‐yl)‐5‐hydroxymethyl‐isoxazone (5).
Yield: 0.29 g (64.8%). m.p.171.22°C (DSC, 10°C min−1);
1H NMR (DMSO‐d6, 500 MHz) δ, ppm: 6.950(s, H, CH),
6.412(s, 2H, NH2), 5.826(t, J = 6.0 Hz, 1H, OH), 4.690(d,
J = 6.0 Hz, 2H, CH2); 13C NMR(DMSO‐d6, 125 MHz) δ,
ppm:174.673, 155.008, 151.859, 138.592, 100.772, 54.613;
IR (KBr) υ: 3472, 3359(NH2), 3131(OH), 2948∼2884
(CH2), 1633,1558(furazan) cm−1; Anal. calcd for C6H6N4O3
: C 39.56, H 3.297, N 30.77; found C 39.76, H 3.450, N
30.47; MS (EI) m/z(%): 182 (M+, 40), 125(100), 68(75), 53
(28),40(15).
Scheme 5
General procedure for the five isoxazones. 3‐Amino‐4‐
chloroximinofurazan (0.4 g, 2.46 mmol) in 30‐mL diethyl ether
was transferred into a three‐necked, round‐bottomed flask fitted
with a mechanical stirrer and a dropping funnel. Hexabutylditin
(1.4 g, 2.46 mmol) and an alkyne (1.2 mmol) were then added.
The reaction mixture was irradiated with a General Electric
sunlamp for 12 h. The reaction temperature was maintained at 25°
C by keeping the distance between the reaction flask and the
sunlamp at about 17 inches [20]. The solvent was evaporated to
dryness, and the residue was recrystallized from ethanol to afford
the pure product.
Single crystal X‐ray diffraction of 4. The suitable crystal of 4
with dimensions of 0.34 × 0.21 × 0.13 mm3 was mounted and
transferred to
a CCD‐equipped diffractometer. The X‐ray
diffraction data were collected using Mo kα (λ = 0.071073 nm)
radiation. Cell parameters were determined in the range of
2.44° < θ < 25.10° at the temperature of 296(2) K. A total of
3880 independent reflections (Rint = 0.0304) were obtained, among
which 1468 observed reflections with I > 2σ(I) were used for the
determination and refinement of the crystal structure in the range of
−18 ≤ h ≤ 29, −5 ≤ k ≤ 5, and −20 ≤ l ≤ 20, respectively. The
coordinates of atom were obtained by direct method. The results
were optimized by the least‐squares method with anisotropic
thermal parameters. The empirical formula was C6H5ClN4O2. The
molecular weight of compound 4 was 200.59. The crystal of
4 belongs to monoclinic, space group C2/c with a = 2.4812(8) nm,
α = 90°, b = 0.48451(16) nm, β = 124.829(3)°, c = 1.6821(6) nm,
γ = 90o, V = 1.6599(9) nm3, Z = 8, Dc = 1.605 g cm−3, μ = 0.431
mm−1, F(000) = 816. The maximum peak and the minimum
peak on the Fourier map were 191 and −353 e·nm−3, respectively.
The refinement was converged with R1 =0.0377, ωR2 =0.0917,
of which, w = 1/[s2(F0)2+(0.0377P)2+0.0000P], P = (F + 2F)/3,
S =1.072. All calculations were corrected by Lp. The crystal
structure resolve and correction were processed using SHELX‐97
program package [22, 23] on Founder −5166, respectively.
3‐(4‐Aminofurazan‐3‐yl)‐4,5‐dihydroxylmethylisoxazone (1).
Yield: 0.35 g (67.1%). m.p.143.55°C, T.p. 310.79°C (DSC, 10°C
min−1); 1H NMR (DMSO‐d6, 500 MHz) δ, ppm: 6.427(s, 2H,
NH2), 5.675(t, J = 6.0 Hz, 1H, OH), 5.121(t, J = 5.0 Hz, 1H,
OH), 4.731(d, J = 6.0 Hz, 2H, CH2), 4.628 (d, J = 5.0 Hz, 2H,
CH2); 13C NMR (DMSO‐d6, 125 MHz) δ, ppm: 170.644,
155.349, 151.150, 138.518, 115.689, 53.217, 51.862; IR (KBr)
υ: 3472, 3349(NH2), 3291(OH), 2956∼2869(CH2), 1635,1552
(furazan) cm−1; Anal. calcd for C7H8N4O4: C 39.62, H 3.774, N
26.41; found C 39.74, H 3.752, N 26.35; MS (EI) m/z(%): 212
(M+,18), 176(35), 155(100), 137(60), 109(35),68(50), 53 (85).
3‐(4‐Aminofurazan‐3‐yl)‐5‐tert‐butylisoxazone (2). Yield: 0.33 g
(64.5%). m.p. 162.82°C (DSC, 10°C min−1); H NMR(DMSO‐d6,
500 MHz) δ, ppm: 6.867(s, H, CH), 6.395(s, 2H, NH2), 1.376
1
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet.842